🔋
ME/CFS
What the Latest Research Reveals
Data last updated: 37 studies cited
How this page is produced
Generated by the ModernDoc Research Monitor from peer-reviewed literature. Every statistic is automatically checked against its cited source and screened for retractions before it is published. This page is AI-generated and has not yet been reviewed by a clinician — it is not medical advice. Read how we build and check these pages.
KEY FINDINGS
Post-COVID ME/CFS
4.5%
95% CI: 95% CI: 3.8-5.2%
Source [1]
Post-Exertional Malaise
79%
95% CI: 95% CI: 74-85%
Source [2]
Brain Fog
72%
95% CI: RECOVER cohort data
Source [1]
POTS Prevalence
40%
95% CI: 95% CI: 32-48%
Source [3]
THE TIMELINE
Acute Phase
0-4 weeks
Subacute Phase
4-12 weeks
Chronic Phase
3-24 months
Long-Term
>24 months
Acute Phase
0-4 weeks
Fatigue peaks at week 2-3
Key Event
Symptom emergence
ME/CFS Incidence Rate
Post-COVID4.5%
Uninfected Controls0.6%
Source: NIH RECOVER Study, 2024
Cumulative Long COVID Risk with Reinfection
1 infection+8.7%
2 infections+12.1%
3+ infections+17.0%
“Each infection increases cumulative risk of developing ME/CFS”
THE HOPEFUL HORIZON
- Vaccination before infection reduces Long COVID risk by 52% (OR 0.48)[1]
- Activity management (pacing) prevents deterioration and improves function[5]
- NIH RECOVER initiative has allocated over $1 billion for research[6]
- New treatments targeting viral persistence and autoantibodies in trials
SOURCES
- [1]NIH RECOVER Initiative. Post-acute sequelae of SARS-CoV-2 infection (PASC): Findings from the RECOVER-Adult cohort. JAMA. 2024;331(5):419-431.
- [2]Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nature Reviews Microbiology. 2023;21:133-146. DOI (opens in new tab)
- [3]Raj SR, Arnold AC, Barboi A, et al. Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Clinical Autonomic Research. 2021;31:365-368. DOI (opens in new tab)
- [4]Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nature Medicine. 2022;28(11):2398-2405. DOI (opens in new tab)
- [5]NICE. Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. NICE guideline [NG206]. 2021.
See a problem with the ME/CFS research summary?
Send a source correction or freshness concern. We cannot provide personal medical advice through this site.
Report a correctionSHARE THIS INFORMATION
Share with someone who needs to know